Oral HIV/AIDS research alliance: Updated case definitions of oral disease endpoints

Journal of Oral Pathology and Medicine

Volumn 38, Issue 6, 2009, Pages 481-488

  Shiboski, C H ^a   Patton, L L ^b   Webster Cyriaque, J Y ^b   Greenspan, D ^a   Traboulsi, R S ^c   Ghannoum, M ^c   Jurevic, R ^d   Phelan, J A ^e   Reznik, D ^f   Greenspan, J S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d CASE WESTERN RESERVE UNIVERSITY   (United States)

^e NEW YORK UNIVERSITY COLLEGE OF DENTISTRY   (United States)

^f EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

AIDS; Epidemiology; HIV; Oral lesions

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; APHTHOUS STOMATITIS; CHEILITIS; CLINICAL RESEARCH; DISEASE ASSOCIATION; DISEASE DURATION; HERPES LABIALIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IDIOPATHIC DISEASE; KAPOSI SARCOMA; LEUKOPLAKIA; MOUTH CANCER; NECROTIZING ULCERATIVE PERIODONTITIS; NONHODGKIN LYMPHOMA; ORAL BIOPSY; ORAL MUCOSAL DISEASE; PAROTID ENLARGEMENT; PERIODONTITIS; PRIORITY JOURNAL; RECURRENT INFECTION; REVIEW; SALIVARY GLAND DISEASE; SALIVARY HYPOFUNCTION; SQUAMOUS CELL CARCINOMA; STOMATITIS; THRUSH; VERRUCA VULGARIS; VINCENT STOMATITIS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-RETROVIRAL AGENTS; CANDIDIASIS, ORAL; CARCINOMA, SQUAMOUS CELL; CHEILITIS; CLINICAL TRIALS AS TOPIC; DEVELOPING COUNTRIES; EPIDEMIOLOGIC STUDIES; GINGIVITIS, NECROTIZING ULCERATIVE; HERPES LABIALIS; HIV INFECTIONS; HUMANS; LEUKOPLAKIA, HAIRY; LYMPHOMA, AIDS-RELATED; LYMPHOMA, NON-HODGKIN; MOUTH DISEASES; MOUTH NEOPLASMS; ORAL ULCER; PAROTID DISEASES; SARCOMA, KAPOSI; STOMATITIS, APHTHOUS; STOMATITIS, HERPETIC; TERMINOLOGY AS TOPIC; UNITED STATES; WARTS;

EID: 67650766309     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2009.00749.x     Document Type: Review

References (39)

1. Feigal DW, Katz MH, Greenspan D, et al. The prevalence of oral lesions in HIV-infected homosexual and bisexual men: three San Francisco epidemiological cohorts. AIDS 1991 5 : 519 25.
2. Katz MH, Greenspan D, Westenhouse J, et al. Progression to AIDS in HIV-infected homosexual and bisexual men with hairy leukoplakia and oral candidiasis. AIDS 1992 6 : 95 100.
3. Glick M, Muzyka BC, Lurie D, Salkin LM. Oral manifestations associated with HIV-related disease as markers for immune suppression and AIDS. Oral Surg Oral Med Oral Pathol 1994 77 : 344 9.
4. Shiboski CH, Hilton JF, Greenspan D, et al. HIV-related oral manifestations in two cohorts of women in San Francisco. J Acquir Immune Defic Syndr 1994 7 : 964 71.
5. Shiboski CH, Hilton JF, Neuhaus JM, Canchola A, Greenspan D. Human immunodeficiency virus-related oral manifestations and gender. A longitudinal analysis. Arch Intern Med 1996 156 : 2249 54.
6. Patton LL, McKaig RG, Eron JJ Jr., Lawrence HP, Strauss RP. Oral hairy leukoplakia and oral candidiasis as predictors of HIV viral load. AIDS 1999 13 : 2174 6.
7. Shiboski CH, Wilson CM, Greenspan D, Hilton JF, Greenspan JS, Moscicki AB. HIV-related oral manifestations among adolescents in a multicenter cohort study. J Adolesc Health 2001 29 : 109 14.
8. Greenspan D, Komaroff E, Redford M, et al. Oral mucosal lesions and HIV viral load in the Women's Interagency HIV Study (WIHS). J Acquir Immune Defic Syndr 2000 25 : 44 50. (Pubitemid 30944971)
9. Ramirez-Amador V, Esquivel-Pedraza L, Sierra-Madero J, Anaya-Saavedra G, Gonzalez-Ramirez I, Ponce-de-Leon S. The changing clinical spectrum of human immunodeficiency virus (HIV)-related oral lesions in 1,000 consecutive patients: a 12-year study in a referral center in Mexico. Medicine (Baltimore) 2003 82 : 39 50. (Pubitemid 36139799)
10. Arribas J, Hernandez-Albujar S, Gonzalez-Garcia J, et al. Impact of protease inhibitor therapy on HIV-related oropharyngeal candidiasis. AIDS 2000 14 : 979 85.
11. Greenspan D, Gange S, Phelan J, et al. Incidence of oral lesions in HIV-1-infected women: reduction with HAART. J Dent Res 2004 83 : 145 50.
12. Nicolatou-Galitis O, Velegraki A, Paikos S, et al. Effect of PI-HAART on the prevalence of oral lesions in HIV-1 infected patients. A Greek study. Oral Dis 2004 10 : 145 50.
13. Patton LL, McKaig RG, Strauss RP, Rogers D, Eron JJ Jr. Changing prevalence of oral manifestations of human immuno-deficiency virus in the era of protease inhibitor therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000 89 : 299 304.
14. Schmidt-Westhausen A, Priepke F, Bergmann F, Reichart P. Decline in the rate of oral opportunistic infections following introduction of highly active antiretroviral therapy. J Oral Pathol Med 2000 29 : 336 41.
15. Ceballos-Salobrena A, Gaitan-Cepeda L, Ceballos-Garcia L, Lezama-Del Valle D. Oral lesions in HIV/AIDS patients undergoing highly active antiretroviral treatment including protease inhibitors: a new face of oral AIDS? AIDS Patient Care STDS 2000 14 : 627 35.
16. Hodgson TA, Greenspan D, Greenspan JS. Oral lesions of HIV disease and HAART in industrialized countries. Adv Dent Res 2006 19 : 57 62.
17. Tappuni AR, Fleming GJ. The effect of antiretroviral therapy on the prevalence of oral manifestations in HIV-infected patients: a UK study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001 92 : 623 8.
18. Umadevi KM, Ranganathan K, Pavithra S, et al. Oral lesions among persons with HIV disease with and without highly active antiretroviral therapy in southern India. J Oral Pathol Med 2007 36 : 136 41.
19. Greenspan D, Canchola A, MacPhail L, Cheike B, Greenspan J. Effect of highly active antiretroviral therapy on frequency of oral warts. Lancet 2001 357 : 1411 2.
20. Cameron JE, Mercante D, O'Brien M, et al. The impact of highly active antiretroviral therapy and immunodeficiency on human papillomavirus infection of the oral cavity of human immunodeficiency virus-seropositive adults. Sex Transm Dis 2005 32 : 703 9.
21. King MD, Reznik DA, O'Daniels CM, Larsen NM, Osterholt D, Blumberg HM. Human papillomavirus-associated oral warts among human immunodeficiency virus-seropositive patients in the era of highly active antiretroviral therapy: an emerging infection. Clin Infect Dis 2002 34 : 641 8.
22. http://www.aactg.org/, accessed on 28 February 2007.
23. Greenspan JS, Barr CE, Sciubba JJ, Winkler JR. Oral manifestations of HIV infection. Definitions, diagnostic criteria, and principles of therapy. The U.S.A. Oral AIDS Collaborative Group. Oral Surg Oral Med Oral Pathol 1992 73 : 142 4.
24. EC-Clearinghouse. Classification and diagnostic criteria for oral lesions in HIV infection. EC-Clearinghouse on Oral Problems Related to HIV Infection and WHO Collaborating Centre on Oral Manifestations of the Immunodeficiency Virus. J Oral Pathol Med 1993 22 : 289 91.
25. Arendorf T, Bredekamp B, Cloete C, Sauer G. Oral manifestations of HIV infection in 600 South African patients. J Oral Pathol Med 1998 27 : 176 9.
26. Chidzonga M. HIV/AIDS orofacial lesions in 156 Zimbabwean patients at referral oral and maxillofacial surgical clinics. Oral Dis 2003 9 : 317 22.
27. Hilton J, Donegan E, Katz M, et al. Development of oral lesions in human immunodeficiency virus-infected transfusion recipients and hemophiliacs. Am J Epidemiol 1997 145 : 164 74.
28. Hodgson T. HIV-associated oral lesions: prevalence in Zambia. Oral Dis 1997 3 : S46 50.
29. Matee M, Scheutz F, Moshy J. Occurrence of oral lesions in relation to clinical and immunological status among HIV-infected adult Tanzanians. Oral Dis 2000 6 : 106 11.
30. Palacio H, Hilton J, Canchola A, Greenspan D. Effect of cigarette smoking on HIV-related oral lesions. J Acquir Immune Defic Syndr 1997 14 : 338 42.
31. Patton LL. Sensitivity, specificity, and positive predictive value of oral opportunistic infections in adults with HIV/AIDS as markers of immune suppression and viral burden. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000 90 : 182 8.
32. Lifson AR, Hilton JF, Westenhouse JL, et al. Time from HIV seroconversion to oral candidiasis or hairy leukoplakia among homosexual and bisexual men enrolled in three prospective cohorts. AIDS 1994 8 : 73 9.
33. Shiboski CH, Neuhaus JM, Greenspan D, Greenspan JS. The effect of receptive oral sex and smoking on the incidence of hairy leukoplakia in HIV-positive gay men. J Acquir Immune Def Synd 1999 21 : 236 42.
34. Clifford GM, Polesel J, Rickenbach M, et al. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst 2005 97 : 425 32.
35. Engels EA, Biggar RJ, Hall HI, et al. Cancer risk in people infected with human immunodeficiency virus in the United States. Int J Cancer 2008 123 : 187 94.
36. Patel P, Hanson DL, Sullivan PS, et al. Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003. Ann Intern Med 2008 148 : 728 36.
37. Dawes C. Physiological factors affecting salivary flow rate, oral sugar clearance, and the sensation of dry mouth in man. J Dent Res 1987 66 Spec No : 648 53.
38. Navazesh M, Christensen C, Brightman V. Clinical criteria for the diagnosis of salivary gland hypofunction. J Dent Res 1992 71 : 1363 9.
39. Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002 61 : 554 8.